Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CITIUS ONCOLOGY, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 1.4M | Aug 12, 2024 | Direct | ||
Citius Pharmaceuticals, Inc. | Chief Medical Officer | Stock Option (Right to Purchase Common Stock) | 300K | Oct 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 1 | $0 | 4/A | Aug 30, 2024 | Chief Medical Officer |
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Chief Medical Officer |
CTXR | Citius Pharmaceuticals, Inc. | Oct 10, 2023 | 1 | $0 | 4 | Oct 12, 2023 | Chief Medical Officer |
CTXR | Citius Pharmaceuticals, Inc. | Oct 4, 2022 | 1 | $0 | 4 | Oct 6, 2022 | Chief Medical Officer |
CTXR | Citius Pharmaceuticals, Inc. | Oct 11, 2021 | 1 | $0 | 4 | Oct 13, 2021 | Chief Medical Officer |